MitraClip Implantation in Younger Patients and Pediatric Populations: 19 Year-Old Patient with Multiple Comorbidities and a Prior Mitral Valve Annuloplasty

Ismail Ates; Zeynettin Kaya; Doruk C. Karaaslan; Deniz Mutlu; Mehmet Cilingiroglu

doi:10.1016/j.carrev.2018.11.008

MitraClip Implantation in Younger Patients and Pediatric Populations: 19 Year-Old Patient with Multiple Comorbidities and a Prior Mitral Valve Annuloplasty

Ismail Ates, Zeynettin Kaya, Doruk C. Karaaslan, Deniz Mutlu, Mehmet Cilingiroglu

Research output: Contribution to journal › Review article › peer-review

1 Citation (Scopus)

Abstract

MitraClip is an effective treatment method for severe mitral regurgitation in high-risk populations in terms of reducing morbidity and frequency of hospitalizations. Efficacy and safety of MitraClip device in elderly population have been established, yet there are only 2 case reports of MitraClip implantation in the younger patients, who generally tend to have less surgical risk (Gorenflo et al.; Joffe et al., 2016). We describe a 19-year-old patient with severe mitral regurgitation with prior mitral valve annuloplasty and received MitraClip implantation due to high-surgical risk.

Original language	English
Pages (from-to)	1027-1030
Number of pages	4
Journal	Cardiovascular Revascularization Medicine
Volume	20
Issue number	11
DOIs	https://doi.org/10.1016/j.carrev.2018.11.008
Publication status	Published - Nov 2019
Externally published	Yes

Keywords

Mitral valve disease
Mitral valve disease
Percutaneous intervention
Percutaneous valve therapy
Structural heart disease intervention

Access to Document

10.1016/j.carrev.2018.11.008

Cite this

@article{1c62fe8ea9f24b72a4054c0c4718c129,

title = "MitraClip Implantation in Younger Patients and Pediatric Populations: 19 Year-Old Patient with Multiple Comorbidities and a Prior Mitral Valve Annuloplasty",

abstract = "MitraClip is an effective treatment method for severe mitral regurgitation in high-risk populations in terms of reducing morbidity and frequency of hospitalizations. Efficacy and safety of MitraClip device in elderly population have been established, yet there are only 2 case reports of MitraClip implantation in the younger patients, who generally tend to have less surgical risk (Gorenflo et al.; Joffe et al., 2016). We describe a 19-year-old patient with severe mitral regurgitation with prior mitral valve annuloplasty and received MitraClip implantation due to high-surgical risk.",

keywords = "Mitral valve disease, Mitral valve disease, Percutaneous intervention, Percutaneous valve therapy, Structural heart disease intervention",

author = "Ismail Ates and Zeynettin Kaya and Karaaslan, {Doruk C.} and Deniz Mutlu and Mehmet Cilingiroglu",

note = "Publisher Copyright: {\textcopyright} 2018",

year = "2019",

month = nov,

doi = "10.1016/j.carrev.2018.11.008",

language = "English",

volume = "20",

pages = "1027--1030",

journal = "Cardiovascular Revascularization Medicine",

issn = "1553-8389",

publisher = "Elsevier Inc.",

number = "11",

}

MitraClip Implantation in Younger Patients and Pediatric Populations: 19 Year-Old Patient with Multiple Comorbidities and a Prior Mitral Valve Annuloplasty. / Ates, Ismail; Kaya, Zeynettin; Karaaslan, Doruk C. et al.
In: Cardiovascular Revascularization Medicine, Vol. 20, No. 11, 11.2019, p. 1027-1030.

Research output: Contribution to journal › Review article › peer-review

TY - JOUR

T1 - MitraClip Implantation in Younger Patients and Pediatric Populations

T2 - 19 Year-Old Patient with Multiple Comorbidities and a Prior Mitral Valve Annuloplasty

AU - Ates, Ismail

AU - Kaya, Zeynettin

AU - Karaaslan, Doruk C.

AU - Mutlu, Deniz

AU - Cilingiroglu, Mehmet

PY - 2019/11

Y1 - 2019/11

N2 - MitraClip is an effective treatment method for severe mitral regurgitation in high-risk populations in terms of reducing morbidity and frequency of hospitalizations. Efficacy and safety of MitraClip device in elderly population have been established, yet there are only 2 case reports of MitraClip implantation in the younger patients, who generally tend to have less surgical risk (Gorenflo et al.; Joffe et al., 2016). We describe a 19-year-old patient with severe mitral regurgitation with prior mitral valve annuloplasty and received MitraClip implantation due to high-surgical risk.

AB - MitraClip is an effective treatment method for severe mitral regurgitation in high-risk populations in terms of reducing morbidity and frequency of hospitalizations. Efficacy and safety of MitraClip device in elderly population have been established, yet there are only 2 case reports of MitraClip implantation in the younger patients, who generally tend to have less surgical risk (Gorenflo et al.; Joffe et al., 2016). We describe a 19-year-old patient with severe mitral regurgitation with prior mitral valve annuloplasty and received MitraClip implantation due to high-surgical risk.

KW - Mitral valve disease

KW - Percutaneous intervention

KW - Percutaneous valve therapy

KW - Structural heart disease intervention

UR - http://www.scopus.com/inward/record.url?scp=85057377582&partnerID=8YFLogxK

U2 - 10.1016/j.carrev.2018.11.008

DO - 10.1016/j.carrev.2018.11.008

M3 - Review article

C2 - 30503037

AN - SCOPUS:85057377582

SN - 1553-8389

VL - 20

SP - 1027

EP - 1030

JO - Cardiovascular Revascularization Medicine

JF - Cardiovascular Revascularization Medicine

IS - 11

ER -

MitraClip Implantation in Younger Patients and Pediatric Populations: 19 Year-Old Patient with Multiple Comorbidities and a Prior Mitral Valve Annuloplasty

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this

MitraClip Implantation in Younger Patients and Pediatric Populations: 19 Year-Old Patient with Multiple Comorbidities and a Prior Mitral Valve Annuloplasty

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this

MitraClip Implantation in Younger Patients and Pediatric Populations: 19 Year-Old Patient with Multiple Comorbidities and a Prior Mitral Valve Annuloplasty